Sponsor

2013/06/14

Could This Company Transform Diabetes Treatment?

Friday, June 14, 2013

Refer a Friend  |  Visit Our Website  |  Unsubscribe

  Advertisers

Could This Company Transform Diabetes Treatment?

 

by Rob Goldman

 

 

I confess I have never been a real big fan of medical devices stocks. However, I know many an analyst and hedge fund manager that covered or bought small medical devices stocks that soared and were eventually acquired for big premiums.

 

Frankly, I have always found it tough to find winners given the lower profitability associated with the space and the difficulties new entrants have getting sales and marketing traction. Still, I know that stocks that fall under the radar may be buys, especially if you can time it just right.

 

Today's profiled stock fits the bill exactly.

 

To read more click here >> or visit http://www.thestockjunction.com

 

 

This Space is Going Higher

 

by Rob Goldman

 

 

Roughly 15 months ago we took the plunge and elected to profile a leading medical marijuana stock. Although the stock pick did not do particularly well (timing is everything, after all), a lot has changed in the industry that warrants a re-visit.

 

The bottom line is that we are in the early stages of the industry. And while there are headwinds looming, there are far more positives than negatives. With that in mind, we are going to provide you with a brain dump of key information at a high level, and then highlight the most prominent name in the space.

 

Despite no change in stance by the U.S. federal government, 19 states and the District of Columbia have approved some sort of medical marijuana program. Based upon the sentiment among several state legislatures, it is likely that most states will approve some form of medical marijuana initiative in the coming months.

 

To read more click here >> or visit http://www.thestockjunction.com

 

 

 

 


Disclaimer & Important Information

TheStockJunction.com is owned and published by Champlain Media, LLC of Richmond, Vermont. Champlain Media is neither a registered investment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes and should not to be construed as an offer to sell or the solicitation of an offer to buy any security.

We encourage you to review our full Disclaimer and Disclosure policies. To view our Disclaimer Policy, please click here. To view our Disclosure Policy, please click here.

You are subscribed with the following email address: ignoble.experiment@arconati.us
To unsubscribe from this newsletter, please click here.


Interested in advertising with us? CLICK HERE!

 

Copyright (c) 2013 The Stock Junction | Privacy Policy

c/o Champlain Media
65 Railroad Street
Richmond, VT 05477
PO Box 790

 

No comments:

Post a Comment

Keep a civil tongue.

Label Cloud

Technology (1464) News (793) Military (646) Microsoft (542) Business (487) Software (394) Developer (382) Music (360) Books (357) Audio (316) Government (308) Security (300) Love (262) Apple (242) Storage (236) Dungeons and Dragons (228) Funny (209) Google (194) Cooking (187) Yahoo (186) Mobile (179) Adobe (177) Wishlist (159) AMD (155) Education (151) Drugs (145) Astrology (139) Local (137) Art (134) Investing (127) Shopping (124) Hardware (120) Movies (119) Sports (109) Neatorama (94) Blogger (93) Christian (67) Mozilla (61) Dictionary (59) Science (59) Entertainment (50) Jewelry (50) Pharmacy (50) Weather (48) Video Games (44) Television (36) VoIP (25) meta (23) Holidays (14)

Popular Posts (Last 7 Days)